References
- Spiller HA, Krenzelok EP, Klein-Schwartz W. Multicenter case series of valproic acid ingestion: serum concentrations and toxicity. J Toxicol Clin Toxicol 2000;38:755-60.
- Roberge RJ, Francis EH 3rd. Use of naloxone in valproic acid overdose: case report and review. J Emerg Med 2002;22:67-70.
- Dharnidharka VR, Fennell RS 3rd, Richard GA. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol 2002;17:312-5.
- Singh SM, McCormick BB, Mustata S, Thompson M, Prasad GV. Extracorporeal management of valproic acid overdose: A large regional experience. J Nephrol 2004;17:43-9.
- Seger DL. Anticonvulsants. In: Haddad LM, Shannon MW, Winchester JF, editors. Clinical management of poisoning and drug overdose. 3rd edition. Philadelphia: WB Saunders; 1998. p. 655-63.
- Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 2000;22:62-5.
- Robinson P, Abbott C. Severe hypothermia in association with sodium valproate overdose. NZ Med J 2005;118:U1681.
- Unal E, Kaya U, Aydin K. Fatal valproate overdose in a newborn baby. Hum Exp Toxicol 2007;26:453-6.
- Hyden H, Cupello A, Palm A. Naloxone reverses the inhibition by sodium valproate of GABA transport across Deiters neuronal plasma membrane [letter]. Ann Neurol 1987;21:416-7.
- Ingels M, Beauchamp J, Clark RF, Williams SR. Delayed valproic acid toxicity: a retrospective case series. Ann Emerg Med 2002;39:616-21.